Search
for
Sort by
Research 391–420 of 1000+
- Applications of steroid drugs entrapped in cyclodextrins
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- CLINICAL UPDATES IN HAIR
- Chapter 17. Selective androgen receptor modulators (SARMs)
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- Nutrition of women with hair loss problem during the period of menopause
- Hirsutism and virilization
- Hirsutism in the Adolescent Female
- Alcohol Exposure During Late Adolescence Increases Drinking in Adult Wistar Rats, an Effect that is not Reduced by Finasteride
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Oligomenorrhoea in Exercising Women
- Androgens in Women – Critical Evaluation of the Methods for Their Determination in Diagnostics of Endocrine Disorders
- Testosterone Therapy in Premenopausal Women
- Hyperandrogenism in Adolescent Girls
- Hirsutism
- The Postpartum Telogen Effluvium Fallacy
- The role of androgen therapy
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Current concepts in the pathogenesis and treatment of acne
- Adrenal steroid precursors exert potent androgenic action in the hamster sebaceous glands of flank organs and ears.
- Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women
- Deslorelin treatment of hyperoestrogenism in neutered ferrets (Mustela putorius furo): a case report
- Microbial harmony in female reproductive health: exploring the impact of intestinal flora on ovarian function and disease pathogenesis
- Male Pattern Baldness
- Hormones
- An update on diagnosis and treatment of female pattern hair loss
- The influence of cyclosporine A therapy on sex hormone levels in pre- and post-menopausal women with primary biliary cirrhosis
- Clinical use of 5α-reductase inhibitors
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database